Glasdegib plus intensive or non-intensive chemotherapy for untreated acute myeloid leukemia: results from the randomized, phase 3 BRIGHT AML 1019 trial
格拉司吉布联合强化或非强化化疗治疗未经治疗的急性髓系白血病:来自随机、3期BRIGHT AML 1019试验的结果
期刊:Leukemia
影响因子:13.4
doi:10.1038/s41375-023-02001-z
Sekeres, Mikkael A; Montesinos, Pau; Novak, Jan; Wang, Jianxiang; Jeyakumar, Deepa; Tomlinson, Benjamin; Mayer, Jiri; Jou, Erin; Robak, Tadeusz; Taussig, David C; Dombret, Hervé; Merchant, Akil; Shaik, Naveed; O'Brien, Thomas; Roh, Whijae; Liu, Xueli; Ma, Wendy; DiRienzo, Christine G; Chan, Geoffrey; Cortes, Jorge E